New hope for tough stomach and colon cancers: experimental drug enters human testing
Disease control
Recruiting now
This study is testing a new drug called DR30206 in combination with standard treatments for advanced gastrointestinal cancers like colorectal, stomach, and esophageal cancer. Researchers aim to find the safest and most effective dose and see if the combination helps shrink tumors…
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC